Previous Article | Next Article ![]()
Journal of Clinical Microbiology, February 2007, p. 675, Vol. 45, No. 2
0095-1137/07/$08.00+0 doi:10.1128/JCM.02194-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.
| LETTER TO THE EDITOR |
|
|
|---|
In spring 2006, we encountered the case of an 83-year-old female with a urinary tract infection due to E. corrodens. The patient was referred to the Hospital of Sursee (Switzerland) with general malaise, abdominal pain, burning during micturition, and pollakiuria. Chronic lymphatic leukemia had been diagnosed in 2003. Prior to admission, the patient had a 2-year history of recurrent urinary tract infections. However, no infective agent could be isolated from her urine. There was also a history of recurrent anal prolapse and sigmoidal diverticulitis. Analysis of catheterized spot urine showed an alkaline pH of 9.0, no nitrite, protein of 1 g/liter, more than 500 leukocytes per µl, and large quantities of erythrocytes and bacteria.
On cystine-lactose-electrolyte-deficient agar (UrinAX CL/MC/E; AxonLab AG, Baden, Switzerland) hypochlorite-smelling colonies (105 CFU/ml) were detected, together with a few colonies of viridans streptococci (<104 CFU/ml). The latter were considered contaminants after Aerococcus urinae had been excluded. Identification of the gram-negative rods yielded Eikenella corrodens. On sheep blood agar, pit-forming colonies were detected. Microscopy revealed slender, gram-negative rods which did not grow on MacConkey agar, were nonfermentative on triple sugar iron agar (group IV), and were positive for oxidase, nitrate reductase, and ornithine decarboxylase. The rods were nonmotile; exhibited negative results for catalase, urease, and indole; and did not ferment glucose, sucrose, and maltose. Since no standards for the disk diffusion assay are available from the Clinical and Laboratory Standards Institute (CLSI) for this organism, the antibiogram was read visually and large zones of inhibition were observed with penicillin, cefalotin, cefuroxime, cefoxitin, ceftriaxone, ceftazidime, ciprofloxacin, gentamicin, trimethoprim-sulfamethoxazole, and colistin. When an Etest was used (AB Biodisk, Solna, Sweden), the MICs of penicillin and ciprofloxacin were found to be 0.75 mg/liter and 0.012 mg/liter, respectively. Susceptibility of this organism to a broad range of antibiotics is commonly encountered (3, 7). Gene sequencing (16S rRNA gene) confirmed the species identification (sequence homology, 379/380 nucleotides, i.e., 99.7%; NCBI BLAST, http://www.ncbi.nlm.nih.gov). Therapy was initiated with 400 mg ciprofloxacin intravenously twice a day for 3 days. In a subsequent urine specimen collected from a permanent catheter 1 week after the end of therapy, E. corrodens could no longer be detected.
The organism is mainly found in mixed infections with aerobic and anaerobic bacteria, especially accompanying oral flora (1, 7, 8). There is little doubt that E. corrodens represents an opportunistic pathogen (3, 7), especially in combination with immunosuppressive conditions (2, 4, 7). Nevertheless, E. corrodens' flimsy and often delayed growth may lead to its underdetection. Our patient had two risk factors which may have contributed to susceptibility to infection: (i) recurrent anal prolapse may promote colonization of the lower urinary tract with this intestinal commensal microorganism and (ii) chronic lymphatic leukemia may have favored progression to infection. Thus, several facts point to a causative role of E. corrodens in the reported immunocompromised patient's urinary tract infection: (i) there were clinical and laboratory signs of lower urinary tract infection, (ii) E. corrodens was the prevailing microorganism recovered from an appropriate urine specimen, (iii) anal prolapse can be considered a risk factor for colonization and infection of the urinary tract by an intestinal commensal, and (iv) there was a complete clinical and bacteriological recovery from the urinary tract infection after appropriate antibiotic therapy.
This report demonstrates that E. corrodens is able to cause urinary tract infections, especially when additional risk factors are present.
Published ahead of print on 22 November 2006. |
|
|---|
|
Michael Hombach*
Department of Medical Microbiology, Center for Laboratory Medicine, Kantonsspital Lucerne Lucerne, 6000 Lucerne, Switzerland
Hans R. Frey
Gaby E. Pfyffer
| ||||||
| * Phone: 41 41 205 37 06, Fax: 41 41 205 37 05, E-mail: michael.hombach{at}ksl.ch |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»